Physician profile
Jay A Robinson
NPI 1811972995
$3,040.71
in general payments reported to CMS, 2019-2025
20 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $756 · 2021: $953 · 2022: $310 · 2023: $286 · 2024: $68.93 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $746.80 | 2019-2025 | Ozempic |
| Amarin Pharma, INC. | $436.75 | 2019-2022 | |
| Pfizer INC. | $347.63 | 2019-2023 | |
| Amgen INC. | $262.34 | 2020-2024 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $241.28 | 2019-2022 | |
| Lilly USA, LLC | $223.50 | 2019-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $154.98 | 2019-2021 | |
| Astellas Pharma US INC | $145.70 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.72 | 2019-2024 | Xifaxan |
| Abbvie INC. | $66.73 | 2021-2025 | |
| Boston Scientific Corporation | $47.57 | 2020-2025 | Watchman Flx |
| Abbott Laboratories | $46.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $45.93 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $44.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.25 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $34.77 | 2022 | |
| Glaxosmithkline, LLC. | $24.84 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.10 | 2021 | |
| Inspire Medical Systems, INC. | $18.19 | 2025 | Inspire |
| Sanofi Pasteur INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.